Register entry
- Registered sites
- 1
- Active NDC listings
- 12
- Live patents
- 0
- Countries
- 1
- Base
- South Korea
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| CKD Bio Corporation | 292, Sinwon-ro, Danwon-gu, Ansan-si, Gyeonggi-do 156-04, Korea, South (KOR) | Active ingredient (API) manufacture | 3002806679631168804 |
Catalogue
Drug listings by form and route
1212 active NDC listings: 10 bulk ingredient, 2 drug for further processing. By marketing category: BULK INGREDIENT 10, DRUG FOR FURTHER PROCESSING 2.
| Dosage form | NDCs |
|---|---|
| powder | 12 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| ckd bio corporation | 12 |
Catalogue
Marketed products
12| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | ACARBOSE | powder | 52972-0035BULK INGREDIENT |
| - | CLAVULANATE POTASSIUM | powder | 52972-0031BULK INGREDIENT |
| - | CLAVULANATE POTASSIUM | powder | 52972-0033DRUG FOR FURTHER PROCESSING |
| - | CLAVULANATE POTASSIUM | powder | 52972-0034DRUG FOR FURTHER PROCESSING |
| - | CYCLOSPORINE | powder | 52972-0027BULK INGREDIENT |
| - | DEMECLOCYCLINE HYDROCHLORIDE | powder | 52972-0030BULK INGREDIENT |
| - | MYCOPHENOLATE MOFETIL | powder | 52972-0037BULK INGREDIENT |
| - | RIFAMPIN | powder | 52972-0026BULK INGREDIENT |
| - | RIFAMYCIN O | powder | 52972-0038BULK INGREDIENT |
| - | RIFAMYCIN SODIUM | powder | 52972-0036BULK INGREDIENT |
| - | Tacrolimus | powder | 52972-0040BULK INGREDIENT |
| - | Vancomycin Hydrochloride | powder | 52972-0039BULK INGREDIENT |
Compare
Comparable companies in South Korea
- CELLTRION Inc1 site · 36 NDC
- SUNJIN BEAUTY SCIENCE CO., LTD.1 site · 27 NDC
- YS Life Science Co., Ltd.1 site · 14 NDC
- TAEKYUNG SBC Co LTD1 site · 13 NDC
- Yuhan Chemical Inc1 site · 9 NDC
- K.S.PEARL CO., LTD.1 site · 8 NDC
- Kowon International Korea Co., Ltd.1 site · 5 NDC
- Nanogen Co.,Ltd.1 site · 5 NDC
- Hanil Chemical Ind. Co., Ltd.1 site · 4 NDC
- AK BIOPHARM CO., LTD.1 site · 1 NDC
Enquiry
Common questions
- Is CKD Bio Corporation FDA approved?
- CKD Bio Corporation holds 1 FDA-registered establishment in South Korea. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are CKD Bio Corporation's drugs manufactured?
- The FDA register lists Gyeonggi-do 156-04. Registered operations: active ingredient (API) manufacture.
- What drugs does CKD Bio Corporation make?
- 12 products are listed under CKD Bio Corporation in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.